Literature DB >> 7964167

IgE and eosinophil regulation in a murine model of allergic aspergillosis.

V P Kurup1, H Choi, P S Murali, R L Coffman.   

Abstract

Exposure of BALB/c mice to Aspergillus fumigatus (Af), the antigen responsible for causing allergic bronchopulmonary aspergillosis in humans, caused elevated levels of serum immunoglobulin E (IgE) and peripheral blood and lung eosinophilia similar to that observed in the human disease. We have investigated the role of interleukin-4 (IL-4), IL-5 and interferon-gamma in regulating IgE and eosinophilia in the mouse model. Animals were immunized by intraperitoneal injections of soluble Af antigens adsorbed to alum. These animals developed elevated IgE and Af specific IgG1 and were then treated with anticytokine monoclonal antibodies before the final exposure to particulate Af antigens by the intranasal route. The results showed that anti-IL-5 abrogated eosinophilia in mice, while those treated with anti-IL-4 retained the same or reduced IgE levels compared to pretreatment levels. All anti-IL-5, anti-IFN-gamma, and control antibody-treated animals showed enhanced IgE levels. Anti-IFN-gamma treatment of mice resulted in marked enhancement of eosinophilia compared to all other groups. Eosinophil numbers observed in the histological sections of the lungs confirmed the eosinophilia detected in the peripheral blood. These results indicate that the increase in IgE and eosinophils after exposure to Af antigens in BALB/c mice are due to Af-induced production of IL-4 and IL-5 and that both IgE and eosinophilia are independently regulated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964167     DOI: 10.1002/jlb.56.5.593

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  Deposition of eosinophil granule proteins in liver associated with allergic bronchopulmonary candidiasis.

Authors:  K Tajima; K Maeda; S Fuyama; T Katagiri; T Kato
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma.

Authors:  P D Mehlhop; M van de Rijn; A B Goldberg; J P Brewer; V P Kurup; T R Martin; H C Oettgen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Vitamin D regulation of OX40 ligand in immune responses to Aspergillus fumigatus.

Authors:  Nikki Lynn Hue Nguyen; Kong Chen; Jeremy McAleer; Jay K Kolls
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

4.  Enzyme immunoassays for specific IgG and IgE antibodies to Pichia pastoris components in normal humans.

Authors:  W Ohtani; K Kobayashi; T Ohmura
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  A comparison between intratracheal and inhalation delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice.

Authors:  Amali E Samarasinghe; Scott A Hoselton; Jane M Schuh
Journal:  Fungal Biol       Date:  2010-10-08

Review 7.  Animal models of allergic bronchopulmonary aspergillosis.

Authors:  Viswanath P Kurup; Gabriele Grunig
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

8.  Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis.

Authors:  Banani Banerjee; Kevin J Kelly; Jordan N Fink; James D Henderson; Naveen K Bansal; Viswanath P Kurup
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression.

Authors:  Thomas X Lu; Ariel Munitz; Marc E Rothenberg
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

Review 10.  Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2013-06-02       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.